Macro
Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.
month values ▾
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.42 | +0.10 | +0.10 | +0.10 | +0.10 | +0.20 | +0.20 | +0.20 | +0.20 | +0.10 | +0.12 | +0.00 |
The healthcare sector holds neutral sentiment this month despite heightened pressure on cost structures, as the high-profile Amazon-Berkshire-JPMorgan cost-cutting venture signals intensified scrutiny on pricing and efficiency across providers, payers, and pharmaceuticals. While the initiative remains in early stages, its potential to reshape care delivery and procurement practices tempers near-term optimism, even as broader market conditions remain stable. No offsetting positive catalysts have emerged to shift the balance, leaving sector sentiment flat.
How this mood is scored ▾
Amazon, Berkshire Hathaway, and JPMorgan Chase are forming an independent, not-for-profit healthcare venture focused on reducing costs and improving care for their U.S. employees through technology. The announcement triggered significant declines in shares of pharmacy chains, drug distributors, and health insurers, reflecting market concerns over potential disruption. The initiative, still in early planning, signals a major challenge to traditional healthcare players and could reshape parts of the sector if scaled.
On November 28, 2018 CVS Health closed its roughly $69 billion purchase of insurer Aetna, combining a retail pharmacy chain, a leading pharmacy-benefit manager and a major health insurer under one roof. Cleared after Department of Justice review, the deal accelerated vertical integration in U.S. healthcare and pressured rivals across pharmacy, insurance and PBM segments.